(BXP) Boston Properties - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1011211018
Stock:
Total Rating 39
Risk 68
Buy Signal -0.72
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | 0.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.29 |
| Alpha | -25.68 |
| Character TTM | |
|---|---|
| Beta | 1.039 |
| Beta Downside | 1.171 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.83% |
| CAGR/Max DD | 0.08 |
EPS (Earnings per Share)
Revenue
Description: BXP Boston Properties
BXP, Inc. is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 55 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). As of December 31, 2025, including properties owned by joint ventures, BXP's portfolio totals 52.6 million square feet and 179 properties, including 8 properties under construction/redevelopment. BXP's properties include 157 office properties, 14 retail properties (including one retail property under construction), seven residential properties (including three residential properties under construction) and one hotel. BXP is well-known for its in-house building management expertise and responsiveness to clients' needs. BXP holds a superior track record of developing premium Central Business District (CBD) office buildings, successful mixed-use complexes, suburban office centers and build-to-suit projects for a diverse array of creditworthy clients. BXP actively works to promote its growth and operations in a sustainable and responsible manner. BXP, an S&P 500 company, was founded in 1970 by Mortimer B. Zuckerman and Edward H. Linde and became a public company in 1997.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 276.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.40 > 1.0 |
| NWC/Revenue: 54.43% < 20% (prev 55.13%; Δ -0.69% < -1%) |
| CFO/TA 0.03 > 3% & CFO 837.4m > Net Income 276.9m |
| Net Debt (15.88b) to EBITDA (1.94b): 8.18 < 3 |
| Current Ratio: 2.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (159.1m) vs 12m ago 1.05% < -2% |
| Gross Margin: 60.61% > 18% (prev 0.48%; Δ 6013 % > 0.5%) |
| Asset Turnover: 13.33% > 50% (prev 13.06%; Δ 0.27% > 0%) |
| Interest Coverage Ratio: 1.60 > 6 (EBITDA TTM 1.94b / Interest Expense TTM 640.8m) |
Altman Z'' 0.34
| A: 0.07 (Total Current Assets 3.37b - Total Current Liabilities 1.48b) / Total Assets 26.17b |
| B: -0.06 (Retained Earnings -1.67b / Total Assets 26.17b) |
| C: 0.04 (EBIT TTM 1.02b / Avg Total Assets 26.13b) |
| D: -0.18 (Book Value of Equity -3.36b / Total Liabilities 18.48b) |
| Altman-Z'' Score: 0.34 = B |
Beneish M -3.78
| DSRI: 0.96 (Receivables 1.65b/1.68b, Revenue 3.48b/3.41b) |
| GMI: 0.79 (GM 60.61% / 47.99%) |
| AQI: 0.11 (AQ_t 0.09 / AQ_t-1 0.85) |
| SGI: 1.02 (Revenue 3.48b / 3.41b) |
| TATA: -0.02 (NI 276.9m - CFO 837.4m) / TA 26.17b) |
| Beneish M-Score: -3.78 (Cap -4..+1) = AAA |
What is the price of BXP shares?
As of February 25, 2026, the stock is trading at USD 59.50 with a total of 1,933,142 shares traded.
Over the past week, the price has changed by -1.91%, over one month by -8.14%, over three months by -14.93% and over the past year by -9.28%.
Over the past week, the price has changed by -1.91%, over one month by -8.14%, over three months by -14.93% and over the past year by -9.28%.
Is BXP a buy, sell or hold?
Boston Properties has received a consensus analysts rating of 3.55.
Therefor, it is recommend to hold BXP.
- StrongBuy: 6
- Buy: 3
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the BXP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.5 | 28.6% |
| Analysts Target Price | 76.5 | 28.6% |
BXP Fundamental Data Overview February 21, 2026
P/E Trailing = 35.7586
P/E Forward = 39.0625
P/S = 3.2749
P/B = 1.9138
P/EG = 0.3716
Revenue TTM = 3.48b USD
EBIT TTM = 1.02b USD
EBITDA TTM = 1.94b USD
Long Term Debt = 15.86b USD (from longTermDebt, last quarter)
Short Term Debt = 750.0m USD (from shortTermDebt, last quarter)
Debt = 17.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.88b USD (from netDebt column, last quarter)
Enterprise Value = 26.89b USD (11.01b + Debt 17.36b - CCE 1.48b)
Interest Coverage Ratio = 1.60 (Ebit TTM 1.02b / Interest Expense TTM 640.8m)
EV/FCF = 63.64x (Enterprise Value 26.89b / FCF TTM 422.6m)
FCF Yield = 1.57% (FCF TTM 422.6m / Enterprise Value 26.89b)
FCF Margin = 12.13% (FCF TTM 422.6m / Revenue TTM 3.48b)
Net Margin = 7.95% (Net Income TTM 276.9m / Revenue TTM 3.48b)
Gross Margin = 60.61% ((Revenue TTM 3.48b - Cost of Revenue TTM 1.37b) / Revenue TTM)
Gross Margin QoQ = 60.23% (prev 60.83%)
Tobins Q-Ratio = 1.03 (Enterprise Value 26.89b / Total Assets 26.17b)
Interest Expense / Debt = 0.87% (Interest Expense 150.3m / Debt 17.36b)
Taxrate = 21.0% (US default 21%)
NOPAT = 808.0m (EBIT 1.02b * (1 - 21.00%))
Current Ratio = 2.28 (Total Current Assets 3.37b / Total Current Liabilities 1.48b)
Debt / Equity = 3.37 (Debt 17.36b / totalStockholderEquity, last quarter 5.15b)
Debt / EBITDA = 8.18 (Net Debt 15.88b / EBITDA 1.94b)
Debt / FCF = 37.58 (Net Debt 15.88b / FCF TTM 422.6m)
Total Stockholder Equity = 5.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.06% (Net Income 276.9m / Total Assets 26.17b)
RoE = 5.34% (Net Income TTM 276.9m / Total Stockholder Equity 5.18b)
RoCE = 4.86% (EBIT 1.02b / Capital Employed (Equity 5.18b + L.T.Debt 15.86b))
RoIC = 3.81% (NOPAT 808.0m / Invested Capital 21.23b)
WACC = 4.20% (E(11.01b)/V(28.37b) * Re(9.74%) + D(17.36b)/V(28.37b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF] Terminal Value 86.30% ; FCFF base≈567.9m ; Y1≈565.6m ; Y5≈594.0m
[DCF] Fair Price = 11.65 (EV 17.73b - Net Debt 15.88b = Equity 1.85b / Shares 158.5m; r=5.90% [WACC]; 5y FCF grow -1.05% → 2.90% )
EPS Correlation: -21.76 | EPS CAGR: -3.59% | SUE: 0.55 | # QB: 0
Revenue Correlation: 97.52 | Revenue CAGR: 4.10% | SUE: 2.03 | # QB: 16
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.060 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.07 | Chg30d=+0.023 | Revisions Net=+0 | Growth EPS=+23.4% | Growth Revenue=-0.7%
EPS next Year (2027-12-31): EPS=2.33 | Chg30d=-0.085 | Revisions Net=-1 | Growth EPS=+12.3% | Growth Revenue=+3.0%
[Gordon] Analyst Rev G=-1.6% | Discount Rate=9.7% | Earnings Yield=2.8% | Net Margin=8.0% | ROE=5.3% | Plowback=-29.4% | Payout=129.4%
[Gordon] Breakeven Revenue = 12.30b USD (current 3.48b)
[Gordon] Implied Growth Rate = 6.9% (Discount Rate 9.7% - Earnings Yield 2.8%)
[Gordon] Growth Spread = -8.5% (Analyst -1.6% - Implied 6.9%)
P/E Forward = 39.0625
P/S = 3.2749
P/B = 1.9138
P/EG = 0.3716
Revenue TTM = 3.48b USD
EBIT TTM = 1.02b USD
EBITDA TTM = 1.94b USD
Long Term Debt = 15.86b USD (from longTermDebt, last quarter)
Short Term Debt = 750.0m USD (from shortTermDebt, last quarter)
Debt = 17.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.88b USD (from netDebt column, last quarter)
Enterprise Value = 26.89b USD (11.01b + Debt 17.36b - CCE 1.48b)
Interest Coverage Ratio = 1.60 (Ebit TTM 1.02b / Interest Expense TTM 640.8m)
EV/FCF = 63.64x (Enterprise Value 26.89b / FCF TTM 422.6m)
FCF Yield = 1.57% (FCF TTM 422.6m / Enterprise Value 26.89b)
FCF Margin = 12.13% (FCF TTM 422.6m / Revenue TTM 3.48b)
Net Margin = 7.95% (Net Income TTM 276.9m / Revenue TTM 3.48b)
Gross Margin = 60.61% ((Revenue TTM 3.48b - Cost of Revenue TTM 1.37b) / Revenue TTM)
Gross Margin QoQ = 60.23% (prev 60.83%)
Tobins Q-Ratio = 1.03 (Enterprise Value 26.89b / Total Assets 26.17b)
Interest Expense / Debt = 0.87% (Interest Expense 150.3m / Debt 17.36b)
Taxrate = 21.0% (US default 21%)
NOPAT = 808.0m (EBIT 1.02b * (1 - 21.00%))
Current Ratio = 2.28 (Total Current Assets 3.37b / Total Current Liabilities 1.48b)
Debt / Equity = 3.37 (Debt 17.36b / totalStockholderEquity, last quarter 5.15b)
Debt / EBITDA = 8.18 (Net Debt 15.88b / EBITDA 1.94b)
Debt / FCF = 37.58 (Net Debt 15.88b / FCF TTM 422.6m)
Total Stockholder Equity = 5.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.06% (Net Income 276.9m / Total Assets 26.17b)
RoE = 5.34% (Net Income TTM 276.9m / Total Stockholder Equity 5.18b)
RoCE = 4.86% (EBIT 1.02b / Capital Employed (Equity 5.18b + L.T.Debt 15.86b))
RoIC = 3.81% (NOPAT 808.0m / Invested Capital 21.23b)
WACC = 4.20% (E(11.01b)/V(28.37b) * Re(9.74%) + D(17.36b)/V(28.37b) * Rd(0.87%) * (1-Tc(0.21)))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF] Terminal Value 86.30% ; FCFF base≈567.9m ; Y1≈565.6m ; Y5≈594.0m
[DCF] Fair Price = 11.65 (EV 17.73b - Net Debt 15.88b = Equity 1.85b / Shares 158.5m; r=5.90% [WACC]; 5y FCF grow -1.05% → 2.90% )
EPS Correlation: -21.76 | EPS CAGR: -3.59% | SUE: 0.55 | # QB: 0
Revenue Correlation: 97.52 | Revenue CAGR: 4.10% | SUE: 2.03 | # QB: 16
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.060 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.07 | Chg30d=+0.023 | Revisions Net=+0 | Growth EPS=+23.4% | Growth Revenue=-0.7%
EPS next Year (2027-12-31): EPS=2.33 | Chg30d=-0.085 | Revisions Net=-1 | Growth EPS=+12.3% | Growth Revenue=+3.0%
[Gordon] Analyst Rev G=-1.6% | Discount Rate=9.7% | Earnings Yield=2.8% | Net Margin=8.0% | ROE=5.3% | Plowback=-29.4% | Payout=129.4%
[Gordon] Breakeven Revenue = 12.30b USD (current 3.48b)
[Gordon] Implied Growth Rate = 6.9% (Discount Rate 9.7% - Earnings Yield 2.8%)
[Gordon] Growth Spread = -8.5% (Analyst -1.6% - Implied 6.9%)